3 Inner Struggles During Active Surveillance
Question: What goes up and hasn’t come down? Answer: The use of Active Surveillance in the U.S. A February, 2019 study[i] examined U.S. management trends for low-risk prostate cancer since 2010. Prior to that, the standard of care for low-to-intermediate risk PCa was an “elephant gun” approach aimed at eradicating PCa by obliterating the gland. keep reading